About Reliant Glycosciences
Reliant Glycosciences is a company based in Birmingham (United States) founded in 2015 by Dana V Rizk, William Placzek, Bruce Julian, Matthew B Renfrow, and Jan Novak. Reliant Glycosciences offers products and services including GalD Assay. Reliant Glycosciences operates in a competitive market with competitors including SphingoTec, Astute Medical, Proteomics International, Calciscon and Astek Diagnostics, among others.
- Headquarter Birmingham, United States
- Founders Dana V Rizk, William Placzek, Bruce Julian, Matthew B Renfrow, Jan Novak
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Reliant Glycosciences, Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$977.76 K (USD), Grant
Jun 20, 2024
-
Investors
HHS
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Reliant Glycosciences
Reliant Glycosciences offers a comprehensive portfolio of products and services, including GalD Assay.
Measures serum levels of Gd-IgA1 for IgA nephropathy diagnosis and prognosis.
People of Reliant Glycosciences
Unlock access to complete
Unlock access to complete
Funding Insights of Reliant Glycosciences
Investors in Reliant Glycosciences
Reliant Glycosciences has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Innovate Alabama.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Innovate Alabama is focused on fostering innovation and economic growth.
|
Locked | Locked | Locked |
Investor details for Reliant Glycosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Reliant Glycosciences
Investment portfolio details for Reliant Glycosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Reliant Glycosciences
Detailed financials for Reliant Glycosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Reliant Glycosciences Comparisons
Peer comparison for Reliant Glycosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Reliant Glycosciences
Reliant Glycosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SphingoTec, Astute Medical, Proteomics International, Calciscon and Astek Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biomarker-based diagnostic solutions for cancer and cardiovascular diseases are developed.
|
|
| Locked | Locked | Locked |
Biomarkers are identified for diagnosing high-risk medical conditions.
|
|
| Locked | Locked | Locked |
Medical technology company at the forefront of predictive diagnostics and bio-analytical services
|
|
| Locked | Locked | Locked |
Blood-based IVD developed to assess pathological calcification propensity.
|
|
| Locked | Locked | Locked |
Blood test diagnostic devices are manufactured by Astek Diagnostics.
|
|
| Locked | Locked | Locked |
Developing devices for analyzing proteins, cancer screening, asthama and infant care management
|
Detailed competitors of Reliant Glycosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Reliant Glycosciences
Complete news archive for Reliant Glycosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Reliant Glycosciences
Reliant Glycosciences was founded in 2015 and raised its 1st funding round 5 years after it was founded.
Reliant Glycosciences is headquartered in Birmingham, United States. It is registered at Birmingham, Alabama, United States.
Matthew B Renfrow is the current CEO of Reliant Glycosciences. They have also founded this company.
Reliant Glycosciences was founded in 2015 in Birmingham, United States, within the biotechnology sector. Diagnostic assays for chronic kidney disease are developed, with a focus on IgA Nephropathy (IgAN). Proprietary biomarker-based tools are provided to detect Galactose-deficient IgA1 (Gd-IgA1) and the auto-antibody that recognizes it. Operations center on advancing nephropathy detection through these specialized technologies.
Reliant Glycosciences's top competitors include SphingoTec, Proteomics International and Astute Medical.
Reliant Glycosciences offers GalD Assay.
Reliant Glycosciences has 2 investors. Key investors include HHS, and Innovate Alabama.